COMMUNIQUÉS West-GlobeNewswire

Beleave Provides Business Update

15/12/2017 - 02:07

TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that, upon the Company's [...]

Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

15/12/2017 - 01:34

NEW YORK and MELBOURNE, Australia and LEUVEN, Belgium, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) and TiGenix NV (Euronext Brussels:TIG) (Nasdaq: TIG ) today announce that Mesoblast [...]

Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis

15/12/2017 - 01:27

CALGARY, Alberta, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX ) announced today that it has filed its unaudited interim Consolidated Financial Statements and Management [...]

Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

15/12/2017 - 00:22

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae New York, USA, [...]

INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference

15/12/2017 - 00:09

RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq: INCR ), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair [...]

Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote

14/12/2017 - 23:03

SAN RAMON, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ), (“ Galena ”) announced today that its special meeting of stockholders (“ Special Meeting ”), scheduled for December 15, 2017, [...]

iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2017

14/12/2017 - 23:00

BEIJING, Dec. 14, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

BioDelivery Sciences Reacquires ONSOLIS® from Collegium Pharmaceutical

14/12/2017 - 22:31

RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) announced that it has received the required 90-day notice from Collegium Pharmaceutical, Inc. regarding [...]

Wright Medical Group N.V. Announces Acquisition of IMASCAP SAS

14/12/2017 - 22:15

Ensures Exclusive Access to Breakthrough Software Enabling Technology to Further Differentiate Wright’s Product Portfolio and Further Accelerate Growth Opportunities in Wright’s Global Extremities Business Purchase [...]

Spero Therapeutics Announces 3Q17 Operating Results and Pipeline Update

14/12/2017 - 22:15

Raised approximately $83.6 million in gross proceeds from Initial Public Offering Advanced pipeline with initiation of SPR994 Phase 1 trial in October 2017 and SPR741 Phase 1b trial in November 2017 CAMBRIDGE, Mass., [...]

Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries

14/12/2017 - 22:02

Equity lock-up and standstill arrangement between the companies to expire on 31 December 2017 Mechelen, Belgium; 14 December 2017; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the decision to [...]

Global Blood Therapeutics Announces Proposed Public Offering of Common Stock

14/12/2017 - 22:01

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing [...]

Acer Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

14/12/2017 - 22:01

NEWTON, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

Avinger Secures Waiver and Consent to CRG Loan Agreement

14/12/2017 - 22:01

REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and [...]

CDC Manipulation of Vaccine Data Reported in the Journal of American Physicians and Surgeons

14/12/2017 - 20:01

TUCSON, Ariz., Dec. 14, 2017 (GLOBE NEWSWIRE) -- It has been four years since he first received a phone call from a scientist at the Centers for Disease Control and Prevention (CDC) concerning manipulation of vaccine [...]

Stabilisation measures taken and end of stabilisation period

14/12/2017 - 19:02

Company announcement No. 16/2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN This announcement does not constitute [...]

OSE Immunotherapeutics Receives a Grant From French Government Program “Fonds Unique Interministériel” to Explore New Cytotoxic Antibodies

14/12/2017 - 18:00

Company’s Monoclonal Antibody, OSE-703, to be Significant Focus of Research NANTES, France, Dec. 14, 2017 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173) (Mnémo:OSE), today announces that the Company [...]

Medifirst Solutions Announces Agreement With Life Science Quest, LLC.

14/12/2017 - 17:53

FREEHOLD, NJ, Dec. 14, 2017 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 novembre 2017

14/12/2017 - 17:42

Communiqué de presse Villepinte, le 14 décembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]